Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7109 USD | -1.26% | -4.10% | -13.48% |
03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | Camac Partners Provides Information to Shareholders | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.48% | 25.87M | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.59% | 23.47B | |
-13.89% | 21.9B | |
-6.03% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Chardan Downgrades Forte Biosciences to Sell From Buy, Adjusts Price Target to $4 From $105; Shares Slide 80% Premarket